A share price of Medpace Holdings Inc [MEDP] is currently trading at $337.41, up 1.38%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MEDP shares have gain 5.71% over the last week, with a monthly amount drifted -6.53%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medpace Holdings Inc [NASDAQ: MEDP] stock has seen the most recent analyst activity on October 23, 2024, when Robert W. Baird downgraded its rating to a Neutral and also revised its price target to $349 from $413. On September 27, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $350 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $345 on September 25, 2024. Truist initiated its recommendation with a Hold and recommended $415 as its price target on August 01, 2024. TD Cowen started tracking with a Buy rating for this stock on May 29, 2024, and assigned it a price target of $452. In a note dated May 28, 2024, Mizuho initiated an Buy rating and provided a target price of $435 on this stock.
Medpace Holdings Inc experienced fluctuations in its stock price throughout the past year between $302.01 and $459.77. Currently, Wall Street analysts expect the stock to reach $347 within the next 12 months. Medpace Holdings Inc [NASDAQ: MEDP] shares were valued at $337.41 at the most recent close of the market. An investor can expect a potential return of 2.84% based on the average MEDP price forecast.
Analyzing the MEDP fundamentals
Trailing Twelve Months sales for Medpace Holdings Inc [NASDAQ:MEDP] were 2.11B which represents 7.66% growth. Gross Profit Margin for this corporation currently stands at 0.31% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.19, Equity is 0.51 and Total Capital is 0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 327.44 points at the first support level, and at 317.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 347.69, and for the 2nd resistance point, it is at 357.97.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Medpace Holdings Inc [NASDAQ:MEDP] is 0.93. Further, the Quick Ratio stands at 0.93, while the Cash Ratio is 0.61. Considering the valuation of this stock, the price to sales ratio is 4.87, the price to book ratio is 12.49 and price to earnings (TTM) ratio is 26.71.
Transactions by insiders
Recent insider trading involved EWALD STEPHEN P, General Counsel & Corp. Secy., that happened on Feb 27 ’25 when 2.0 shares were purchased. Director, Carley Brian T completed a deal on Feb 24 ’25 to sell 4003.0 shares. Meanwhile, Director Carley Brian T bought 4003.0 shares on Feb 24 ’25.
